Research Grants to Explore Novel TB Interventions, Therapies, Vaccines and Diagnostics
10 October 2024
***********
TB Alliance Awarded $7.35 Million by U.S. Department of Defense for Novel TB Interventions
TB Alliance announced a $7.35 million award through the U.S. Department of Defense. The four-year grant was received within the DOD’s Congressionally Directed Medical Research Programs (CDMRP) for research and development exploring host-directed approaches for treating TB. The project aims to yield preclinical proof-of-concept for at least one novel adjunct TB host-directed therapy and one therapeutic vaccine that will lay a foundation for clinical development of host-directed interventions.
***********
NIH Awards $2.2 Million to UMass Amherst to Explore New TB Therapies
The U.S. National Institutes of Health (NIH) awarded $2.2 million to Alissa Rothchild, assistant professor in the Department of Veterinary and Animal Sciences at the University of Massachusetts Amherst and an expert in TB immunology, to study the very first cells that respond to Mycobacterium tuberculosis – alveolar macrophages.
***********
Chemify announced that it has been awarded a grant from the Bill & Melinda Gates Foundation to discover new drug leads for treating TB and malaria. The grant will support the rapid and efficient design and synthesis of novel small molecules using the company’s proprietary Chemputation technology and workflow.
***********
NIH Awards UAMS $3.7 Million in Quest for More Effective TB Vaccine
The University of Arkansas for Medical Sciences (UAMS) researcher Lu Huang, Ph.D., has received a $3.7 million grant from the U.S. National Institutes of Health (NIH) to support his pursuit of a more effective TB vaccine. The five-year grant will allow Huang to explore new ways to help the body fight TB based on his recent findings.
***********
New Rapid TB Diagnosis Detector to Be Developed
The Aberystwyth University has been awarded funding of almost £1.2 million from the UK Research and Innovation to develop a new detector for TB in humans and animals that can report a result in one hour. The technology will be simple enough to be operated by any healthcare worker or veterinarian. It will be more specific and more sensitive than existing methods as well as significantly quicker than other types of tests.
***********
